A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026. The lawsuit, filed in the United States District Court for the District of Connecticut, alleges that the company made materially false and misleading statements regarding the viability of its acquisition of Fabric Genomics. On May 4, 2026, GeneDx announced a write-off of a $31.3 million impairment loss directly attributable to Fabric, which was only $5.2 million less than what it paid to acquire the firm a year prior, causing its share price to fall more than 49%. Investors have until August 3, 2026, to seek lead plaintiff status through counsel such as Kessler Topaz Meltzer & Check, LLP.
GeneDx Holdings Corp.Securities fraud lawsuit and $31.3M impairment loss from Fabric Genomics acquisition caused share price to fall over 49%
ServiceNow Inc